Genentech expands partnership with molecular glue biotech Orionis

Roche’s subsidiary Genentech is signing a second deal with Orionis Biosciences to expand its search through the world of protein interactions in hopes of developing new cancer drugs. The two companies first partnered in 2023 ...

Related Posts

Intellia's CRISPR therapy likely causes 'permanent' gen...

May 19, 2025  0

Updated: FDA adcomm splits votes on Genentech and J&J c...

May 20, 2025  0

Trump confirms 'most-favored nation' drug price plans

May 12, 2025  0

Comments

Name

Email

Comment

Post Comment